Drug – bio-affecting and body treating compositions – Extract or material containing or obtained from a...
Reexamination Certificate
2006-08-08
2006-08-08
Leith, Patricia (Department: 1655)
Drug, bio-affecting and body treating compositions
Extract or material containing or obtained from a...
C435S254100
Reexamination Certificate
active
07087233
ABSTRACT:
The present invention provides a method for fetal protection by orally administering germination activatedGanoderma lucidumspore powder (“GASP”) to pregnant mammals. GASP demonstrates prophylactic effects on fetal damage in pregnant mammals, particularly humans.
REFERENCES:
patent: 4472907 (1984-09-01), Wada et al.
patent: 5595756 (1997-01-01), Bally et al.
patent: 6210950 (2001-04-01), Johnson et al.
patent: 6316002 (2001-11-01), Liu et al.
patent: 1092765 (2001-04-01), None
patent: 1245235 (2002-10-01), None
Gura, T. Systems for Identifying New Drugs are Often Faulty; Science, Nov. 7, 1997, vol. 278, pp. 1041-1042.
Lee, Seung Y.; Cardiovascular Effects of Mycelium Extract ofGanoderma lucidum: Inhibition of Sympathetic Outflow as a Mechanism of Its Hypotensive Action. Chem Pharm. Bull. vol. 38, p. 1359-1364 (1990).
Kim et al., Int. J. Mol. Med vol. 4(3), p. 273-277 (1999).
Lin et al . J. Ethnopharmacol., vol. 47(1), p. 33-41 (1995).
El Mekkawy, Sahar et al., Anti-HIV-1 and Anti-HIV-A-Protease Substances fromGanoderma lucidumPhytpchemistry, vol. 49(6), p. 1651-1657 (1998).
Wasser, Solomon P., et al., Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective; Crit. Rev. Immunol., vol. 19(1), p. 65-96 (1999).
Miyazaki, Toshio et al., Studies on Fungal PolysaccharidesXXVII, Structural Examination of a Water-soluble. Antitumor Polysaccharide ofGanoderma lucidum; Chem. Pharm. Bull., vol. 29(12), p. 3611-3616 (1981).
Min, Byung-Sun et al., Triterpenes from the Spores ofGanoderma lucidumand Their Inhibitory Activity against HIV-1 Protease. Chem. Pharm. Bull., vol. 46(10), p. 1607-1612 (1998).
Kino, K. et al., An immunomodulating protein, LING ZHI-8(LZ-8) prevents insulitis an non-obese diabetic mice, Diabetologia, vol. 33, p. 713-718 (1990).
Vander Hem et al., LING ZHI-8: Studies of a New Immunomodulating Agent, Transplantation, vol. 60, p. 438-443 (1995).
Kino, Kohsuke et al., Immunomodulator, LZ-8, Prevents Antibody Production in Mice; Int. J. Immunopharmac., vol. 13(8), p. 1109-1115 (1991).
Maruyama, Hirofumi; Antitumor Activity of Sarcodon aspratus (BERK) S. IIO andGanoderma lucidum(FR.) KARST., J. Pharmacobio-Dyn,m vol. 12, p. 118-123 (1989).
Shimizu, Akira et al.; Isolation of an Inhibitor of Platelet Aggregation from a Fungus,Ganoderma lucidum; Chem. Pharm. Bull., vol. 33, p. 3012-3015 (1985).
Morigiwa, Aiko et al.; Angiotension Converting Enzyme-Inhibitory Triterpenes fromGanoderma lucidum; Chem. Pharm. Bull., vol. 34(7), p. 3025-3028 (1986).
Kanmatsuse, Katsuo et al.; Studies onGanoderma lucidum. I. Efficacy against Hypertension and Side Effects;Yakugaku Zasshi, vol. 105(10), p. 942-947 (1985).
Lieu, Chien-Whei et al.; The Effect ofGanoderma lucidumon Induction of Differentiation in Leukemic U937 Cells;Anticancer Research, vol. 12, p. 1211-1216 (1992).
Wang, Sheng-Yuan et al.; The Anti-Tumor Effect ofGanoderma lucidumis Mediated by Cytokines Released From Activiated Macrophages and T Lymphocytes;Int. J. Cancer, vol. 70, p. 699-705 (1997).
O'Neil, Carol E. et al.; Basidiospere Extracts: Evidence for Common Antigenic/Allergenic Determinants;Int. Archs Allergy appl. Immun., vol. 85, p. 161-166 (1988).
Nogami, Mari et al.; Studies onGanoderma lucidumVI. Anti-allergic Effect. (1);Yakugaku Zasshi, vol. 106(7), p. 594-599 (1986), English Abstract.
Gengtao et al.; Some Pharamacological Actions of the Spores ofGanoderma lucidumand the Mycelium of Ganoderma Capense (Lloyd)Teng Cultivated by Submerged Fermentation;Chinese Medical Journal, vol. 92(7), p. 496-500 (1979).
Fu, Huidi et al.; The Clinical Effects ofGanoderma lucidumSpore Preparations in 10 Cases of Atrophic Myotonia:Journal of traditional Chinese Medicine, vol. 2(1), p. 63-65 (1982).
Mizushina, Yoshiyuki et al.; A Mushroom Fruiting Body-Inducing Substance Inhibits Activities of Replicative DNA Polymerases;Biochemical and Biophysical Research Communications, vol. 249, p. 17-22 (1998).
Lin, Lee-Juian et al.; Separation of oxygenated triterpenoids fromGanoderma lucidumby high-performance liquid chromatography;Journal of Chromatography, vol. 410, p. 195-200 (1987).
Kino, Kohsuke et al.; Isolation and Characterization of a New.
Ganoderma lucidumand Panax gingseng inhibit aflatoxin B1 and benzo(a)pyrene-induced mutagenesis inSalmonella typhimuriumTA98 and TA100. B.Y.Y Wong & H.H.L. Wong, Abstracts of the General Meeting of the American Society for Microbiology, (2001), 101, 406-407. (See abstract).
Effect of mycelial culture broth ofGanoderma lucidumof the growth characteristics of human cell lines, W.T Chung et al, Journal of Bioscience and Bioengineering, (2001), 92. 550-555. (See abstract).
WPI Abstract Accession No. 2001-503343/56 & CN 1298741, (University of Zhongshan) (See abstract).
Chung Chee-Keung
Tong Siu Kan
Bingham & McCutchen LLP
Chao Fei-Fei
Chung Chee-Keung
Leith Patricia
LandOfFree
Antimutagenic effects of Ganoderma lucidum spores does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimutagenic effects of Ganoderma lucidum spores, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimutagenic effects of Ganoderma lucidum spores will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674459